| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |